Onderneming Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board
Aandelen
US21833P1030
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01-07-13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 11-04-14 |
Chief Tech/Sci/R&D Officer | 50 | 28/02 | |
Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 01-01-14 |
Avery Catlin
BRD | Director/Board Member | 75 | 01-08-14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01-07-13 |
John Jenkins
BRD | Director/Board Member | 66 | 05-06-18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 08-04-19 |
Yong Ben
BRD | Director/Board Member | 50 | 01-03-23 |
Peter Salzmann
BRD | Director/Board Member | 56 | 06-03-20 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 20-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 686 693 | 10 594 451 ( 99,14 %) | 0 | 99,14 % |
Bedrijfsgegevens
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,74% | 122 mld. | |
+19,17% | 113 mld. | |
+2,42% | 22,66 mld. | |
-17,01% | 21,34 mld. | |
-39,57% | 16,92 mld. | |
-13,73% | 16,68 mld. | |
-16,43% | 16,61 mld. | |
+2,84% | 13,62 mld. | |
+21,79% | 11,04 mld. |
- Beurs
- Aandelen
- Koers CRBP
- Koers
- Onderneming Corbus Pharmaceuticals Holdings Inc